For nascent life science and biotech companies, the initial focus is rightfully on groundbreaking research and development. However, amidst the scientific discovery, a crucial administrative task often gets overlooked: establishing a robust and well-structured Chart of Accounts (COA). Far more than just a list of numbers, your COA is the backbone of your financial system, categorizing every transaction and providing the detailed insights needed for effective financial management. Without a thoughtfully designed COA from day one, startups risk a chaotic financial landscape, making it incredibly difficult to understand cash flow, analyze operational costs, and make informed strategic decisions as they grow.
This thoughtful organization of a COA becomes particularly vital when considering the unique funding landscape of biotech — especially the pursuit of grants. Government and private grants often have stringent reporting requirements, demanding precise expenditure tracking by project, activity, or even specific scientific aims. A well-designed COA allows you to tag and segregate these grant-related expenses, ensuring accurate allocation of funds, facilitating effortless reporting to grantors, and significantly reducing the risk of audit findings. Trying to retrofit a messy COA or manually track grant expenses after the fact can lead to costly errors, wasted time, and potential compliance issues that threaten future funding opportunities.
Life science and biotech startups should invest early in designing a comprehensive COA that not only accommodates standard operational categories but also includes dedicated dimensions for grant-specific tracking, R&D projects, and intellectual property development costs. A well-structured Chart of Accounts isn’t just an accounting detail; it’s a foundational strategic tool that will empower your scientific breakthroughs with sound financial management from the outset.
CBIZ is familiar with the industry’s nuances and grant reporting standards and can help you create a COA that is scalable, compliant, and provides the clear financial visibility essential for strategic decision-making.
© Copyright CBIZ, Inc. All rights reserved. Use of the material contained herein without the express written consent of the firms is prohibited by law. This publication is distributed with the understanding that CBIZ is not rendering legal, accounting or other professional advice. The reader is advised to contact a tax professional prior to taking any action based upon this information. CBIZ assumes no liability whatsoever in connection with the use of this information and assumes no obligation to inform the reader of any changes in tax laws or other factors that could affect the information contained herein. Material contained in this publication is informational and promotional in nature and not intended to be specific financial, tax or consulting advice. Readers are advised to seek professional consultation regarding circumstances affecting their organization.
“CBIZ” is the brand name under which CBIZ CPAs P.C. and CBIZ, Inc. and its subsidiaries, including CBIZ Advisors, LLC, provide professional services. CBIZ CPAs P.C. and CBIZ, Inc. (and its subsidiaries) practice as an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable law, regulations, and professional standards. CBIZ CPAs P.C. is a licensed independent CPA firm that provides attest services to its clients. CBIZ, Inc. and its subsidiary entities provide tax, advisory, and consulting services to their clients. CBIZ, Inc. and its subsidiary entities are not licensed CPA firms and, therefore, cannot provide attest services.